ID   FKBP8_HUMAN             Reviewed;         412 AA.
AC   Q14318; C8C9T5; Q53GU3; Q7Z349; Q86YK6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 2.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP8;
DE            Short=PPIase FKBP8;
DE            EC=5.2.1.8;
DE   AltName: Full=38 kDa FK506-binding protein;
DE            Short=38 kDa FKBP;
DE            Short=FKBP-38;
DE            Short=hFKBP38;
DE   AltName: Full=FK506-binding protein 8;
DE            Short=FKBP-8;
DE   AltName: Full=FKBPR38;
DE   AltName: Full=Rotamase;
GN   Name=FKBP8; Synonyms=FKBP38;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   BCL2 AND BCL2L1/BCLXL, AND SUBCELLULAR LOCATION.
RX   PubMed=12510191; DOI=10.1038/ncb894;
RA   Shirane M., Nakayama K.I.;
RT   "Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria
RT   and inhibits apoptosis.";
RL   Nat. Cell Biol. 5:28-37(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=15105374; DOI=10.1242/dev.01122;
RA   Bulgakov O.V., Eggenschwiler J.T., Hong D.-H., Anderson K.V., Li T.;
RT   "FKBP8 is a negative regulator of mouse sonic hedgehog signaling in
RT   neural tissues.";
RL   Development 131:2149-2159(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), SUBCELLULAR LOCATION,
RP   INTERACTION WITH BCL2L1, AND TISSUE SPECIFICITY.
RC   TISSUE=Retinal pigment epithelium;
RX   PubMed=18385096; DOI=10.1167/iovs.07-1121;
RA   Chen Y., Sternberg P., Cai J.;
RT   "Characterization of a Bcl-XL-interacting protein FKBP8 and its splice
RT   variant in human RPE cells.";
RL   Invest. Ophthalmol. Vis. Sci. 49:1721-1727(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-412 (ISOFORM 1).
RX   PubMed=7543869; DOI=10.1016/0378-1119(95)00216-S;
RA   Lam E., Martin M., Wiederrecht G.;
RT   "Isolation of a cDNA encoding a novel human FK506-binding protein
RT   homolog containing leucine zipper and tetratricopeptide repeat
RT   motifs.";
RL   Gene 160:297-302(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 42-412 (ISOFORM 2).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 54-412 (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16176796; DOI=10.1016/j.bbrc.2005.09.023;
RA   Kang C.B., Feng L., Chia J., Yoon H.S.;
RT   "Molecular characterization of FK-506 binding protein 38 and its
RT   potential regulatory role on the anti-apoptotic protein Bcl-2.";
RL   Biochem. Biophys. Res. Commun. 337:30-38(2005).
RN   [11]
RP   CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=15990872; DOI=10.1038/sj.emboj.7600739;
RA   Edlich F., Weiwad M., Erdmann F., Fanghaenel J., Jarczowski F.,
RA   Rahfeld J.-U., Fischer G.;
RT   "Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin.";
RL   EMBO J. 24:2688-2699(2005).
RN   [12]
RP   FUNCTION, AND ABSENCE OF DIRECT INTERACTION WITH CALCINEURIN.
RX   PubMed=15757646; DOI=10.1016/j.febslet.2004.12.098;
RA   Weiwad M., Edlich F., Erdmann F., Jarczowski F., Kilka S., Dorn M.,
RA   Pechstein A., Fischer G.;
RT   "A reassessment of the inhibitory capacity of human FKBP38 on
RT   calcineurin.";
RL   FEBS Lett. 579:1591-1596(2005).
RN   [13]
RP   INTERACTION WITH BCL2.
RX   PubMed=15733859; DOI=10.1016/j.febslet.2005.01.053;
RA   Kang C.B., Tai J., Chia J., Yoon H.S.;
RT   "The flexible loop of Bcl-2 is required for molecular interaction with
RT   immunosuppressant FK-506 binding protein 38 (FKBP38).";
RL   FEBS Lett. 579:1469-1476(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [15]
RP   INTERACTION WITH BCL2.
RX   PubMed=17090549; DOI=10.1074/jbc.M606181200;
RA   Portier B.P., Taglialatela G.;
RT   "Bcl-2 localized at the nuclear compartment induces apoptosis after
RT   transient overexpression.";
RL   J. Biol. Chem. 281:40493-40502(2006).
RN   [16]
RP   INTERACTION WITH HCV NS5A.
RX   PubMed=16844119; DOI=10.1016/j.febslet.2006.07.002;
RA   Wang J., Tong W., Zhang X., Chen L., Yi Z., Pan T., Hu Y., Xiang L.,
RA   Yuan Z.;
RT   "Hepatitis C virus non-structural protein NS5A interacts with FKBP38
RT   and inhibits apoptosis in Huh7 hepatoma cells.";
RL   FEBS Lett. 580:4392-4400(2006).
RN   [17]
RP   INTERACTION WITH ZFYVE27.
RX   PubMed=18459960; DOI=10.1111/j.1365-2443.2008.01194.x;
RA   Shirane M., Ogawa M., Motoyama J., Nakayama K.I.;
RT   "Regulation of apoptosis and neurite extension by FKBP38 is required
RT   for neural tube formation in the mouse.";
RL   Genes Cells 13:635-651(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   UBIQUITINATION AT LYS-249; LYS-271; LYS-273; LYS-284; LYS-307;
RP   LYS-314; LYS-334; LYS-340; LYS-348; LYS-351 AND LYS-352.
RX   PubMed=25621951; DOI=10.1038/ncb3097;
RA   Cunningham C.N., Baughman J.M., Phu L., Tea J.S., Yu C., Coons M.,
RA   Kirkpatrick D.S., Bingol B., Corn J.E.;
RT   "USP30 and parkin homeostatically regulate atypical ubiquitin chains
RT   on mitochondria.";
RL   Nat. Cell Biol. 17:160-169(2015).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   STRUCTURE BY NMR OF 92-210.
RX   PubMed=16604427; DOI=10.1007/s10858-006-0018-6;
RA   Maestre-Martinez M., Edlich F., Jarczowski F., Weiwad M., Fischer G.,
RA   Luecke C.;
RT   "Solution structure of the FK506-binding domain of human FKBP38.";
RL   J. Biomol. NMR 34:197-202(2006).
RN   [23]
RP   STRUCTURE BY NMR OF 91-205.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RSGI RUH-047, an FKBP domain from human cDNA.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 90-205.
RG   Structural genomics consortium (SGC);
RT   "Structure of the human FK-506 binding protein 8.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS) OF 92-210, METAL-BINDING SITES,
RP   AND MUTAGENESIS OF ASP-149 AND ASP-151.
RX   PubMed=20140889; DOI=10.1002/jmr.1020;
RA   Maestre-Martinez M., Haupt K., Edlich F., Neumann P., Parthier C.,
RA   Stubbs M.T., Fischer G., Lucke C.;
RT   "A charge-sensitive loop in the FKBP38 catalytic domain modulates Bcl-
RT   2 binding.";
RL   J. Mol. Recognit. 24:23-34(2011).
CC   -!- FUNCTION: Constitutively inactive PPiase, which becomes active
CC       when bound to calmodulin and calcium. Seems to act as a chaperone
CC       for BCL2, targets it to the mitochondria and modulates its
CC       phosphorylation state. The BCL2/FKBP8/calmodulin/calcium complex
CC       probably interferes with the binding of BCL2 to its targets. The
CC       active form of FKBP8 may therefore play a role in the regulation
CC       of apoptosis. {ECO:0000269|PubMed:12510191,
CC       ECO:0000269|PubMed:15757646, ECO:0000269|PubMed:16176796}.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0). {ECO:0000269|PubMed:15990872}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:15990872};
CC   -!- SUBUNIT: Homomultimers or heteromultimers (Potential). Forms
CC       heterodimer with calmodulin. When activated by calmodulin and
CC       calcium, interacts with the BH4 domain of BCL2 and weakly with
CC       BCL2L1/BCLX isoform Bcl-X(L). Does not bind and inhibit
CC       calcineurin. Interacts with HCV NS5A. Interacts with ZFYVE27; may
CC       negatively regulate ZFYVE27 phosphorylation.
CC       {ECO:0000269|PubMed:12510191, ECO:0000269|PubMed:15733859,
CC       ECO:0000269|PubMed:16844119, ECO:0000269|PubMed:17090549,
CC       ECO:0000269|PubMed:18385096, ECO:0000269|PubMed:18459960,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-724839, EBI-724839;
CC       Q9WMX2:- (xeno); NbExp=11; IntAct=EBI-724839, EBI-6863748;
CC       P00533:EGFR; NbExp=3; IntAct=EBI-724839, EBI-297353;
CC       Q9GZT9:EGLN1; NbExp=6; IntAct=EBI-724839, EBI-1174818;
CC       O75344:FKBP6; NbExp=2; IntAct=EBI-724839, EBI-744771;
CC       P07900:HSP90AA1; NbExp=7; IntAct=EBI-724839, EBI-296047;
CC       O39474:NS5A (xeno); NbExp=16; IntAct=EBI-724839, EBI-7016711;
CC       B4URF5:PB1 (xeno); NbExp=5; IntAct=EBI-724839, EBI-6050669;
CC       C5E526:PB1 (xeno); NbExp=5; IntAct=EBI-724839, EBI-12577179;
CC       P03431:PB1 (xeno); NbExp=5; IntAct=EBI-724839, EBI-2547514;
CC       Q5EP37:PB1 (xeno); NbExp=3; IntAct=EBI-724839, EBI-12577201;
CC       Q5T4F4:ZFYVE27; NbExp=4; IntAct=EBI-724839, EBI-3892947;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16176796}.
CC       Mitochondrion membrane {ECO:0000305}; Single-pass membrane
CC       protein; Cytoplasmic side {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion membrane
CC       {ECO:0000269|PubMed:12510191, ECO:0000269|PubMed:18385096};
CC       Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Mitochondrion membrane
CC       {ECO:0000269|PubMed:18385096}; Single-pass membrane protein;
CC       Cytoplasmic side {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14318-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14318-2; Sequence=VSP_034486;
CC       Name=3;
CC         IsoId=Q14318-3; Sequence=VSP_047717;
CC         Note=Interacts with BCL2L1/BCLX.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest levels seen in the
CC       brain. Highly abundant in the retina.
CC       {ECO:0000269|PubMed:18385096}.
CC   -!- PTM: Ubiquitinated by PRKN during mitophagy, leading to its
CC       degradation and enhancement of mitophagy. Deubiquitinated by
CC       USP30. {ECO:0000269|PubMed:25621951}.
CC   -!- MISCELLANEOUS: Binds the immunosuppressant FK506 only in its
CC       calmodulin/calcium activated form.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-58 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB00102.1; Type=Miscellaneous discrepancy; Note=The first part of the cDNA maps to the same locus, but in opposite orientation.; Evidence={ECO:0000305};
CC       Sequence=AAH09966.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAD98028.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FKBP8ID40579ch19p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY225339; AAO39020.1; -; mRNA.
DR   EMBL; AY278607; AAQ84561.1; -; mRNA.
DR   EMBL; GQ372970; ACU65096.1; -; mRNA.
DR   EMBL; BX538124; CAD98028.1; ALT_INIT; mRNA.
DR   EMBL; BX647405; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC005387; AAC28753.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84709.1; -; Genomic_DNA.
DR   EMBL; L37033; AAB00102.1; ALT_SEQ; mRNA.
DR   EMBL; AK222838; BAD96558.1; -; mRNA.
DR   EMBL; BC009966; AAH09966.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32961.1; -. [Q14318-2]
DR   CCDS; CCDS77266.1; -. [Q14318-1]
DR   RefSeq; NP_001295302.1; NM_001308373.1. [Q14318-1]
DR   RefSeq; NP_036313.3; NM_012181.4. [Q14318-2]
DR   RefSeq; XP_011526165.1; XM_011527863.1. [Q14318-2]
DR   UniGene; Hs.173464; -.
DR   PDB; 2AWG; X-ray; 1.60 A; A=90-205.
DR   PDB; 2D9F; NMR; -; A=91-211.
DR   PDB; 2F2D; NMR; -; A=92-210.
DR   PDB; 2MF9; NMR; -; A=58-205.
DR   PDB; 3EY6; X-ray; 1.05 A; A=92-210.
DR   PDB; 5MGX; X-ray; 2.18 A; E/F/G/H=91-380.
DR   PDBsum; 2AWG; -.
DR   PDBsum; 2D9F; -.
DR   PDBsum; 2F2D; -.
DR   PDBsum; 2MF9; -.
DR   PDBsum; 3EY6; -.
DR   PDBsum; 5MGX; -.
DR   ProteinModelPortal; Q14318; -.
DR   SMR; Q14318; -.
DR   BioGrid; 117270; 94.
DR   DIP; DIP-42200N; -.
DR   IntAct; Q14318; 66.
DR   MINT; MINT-1338555; -.
DR   STRING; 9606.ENSP00000222308; -.
DR   iPTMnet; Q14318; -.
DR   PhosphoSitePlus; Q14318; -.
DR   SwissPalm; Q14318; -.
DR   BioMuta; FKBP8; -.
DR   DMDM; 193806337; -.
DR   EPD; Q14318; -.
DR   MaxQB; Q14318; -.
DR   PaxDb; Q14318; -.
DR   PeptideAtlas; Q14318; -.
DR   PRIDE; Q14318; -.
DR   DNASU; 23770; -.
DR   Ensembl; ENST00000222308; ENSP00000222308; ENSG00000105701. [Q14318-1]
DR   Ensembl; ENST00000596558; ENSP00000472302; ENSG00000105701. [Q14318-1]
DR   Ensembl; ENST00000597960; ENSP00000471700; ENSG00000105701. [Q14318-2]
DR   Ensembl; ENST00000608443; ENSP00000476767; ENSG00000105701. [Q14318-2]
DR   GeneID; 23770; -.
DR   KEGG; hsa:23770; -.
DR   UCSC; uc002njj.2; human. [Q14318-1]
DR   CTD; 23770; -.
DR   DisGeNET; 23770; -.
DR   GeneCards; FKBP8; -.
DR   HGNC; HGNC:3724; FKBP8.
DR   HPA; CAB025346; -.
DR   HPA; HPA045177; -.
DR   MIM; 604840; gene.
DR   neXtProt; NX_Q14318; -.
DR   OpenTargets; ENSG00000105701; -.
DR   PharmGKB; PA28165; -.
DR   eggNOG; KOG0543; Eukaryota.
DR   eggNOG; COG0545; LUCA.
DR   GeneTree; ENSGT00760000119159; -.
DR   HOVERGEN; HBG051626; -.
DR   InParanoid; Q14318; -.
DR   KO; K09574; -.
DR   OMA; AMYKKML; -.
DR   OrthoDB; EOG091G0AS2; -.
DR   PhylomeDB; Q14318; -.
DR   TreeFam; TF105295; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   SIGNOR; Q14318; -.
DR   ChiTaRS; FKBP8; human.
DR   EvolutionaryTrace; Q14318; -.
DR   GeneWiki; FKBP8; -.
DR   GenomeRNAi; 23770; -.
DR   PRO; PR:Q14318; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105701; -.
DR   CleanEx; HS_FKBP8; -.
DR   ExpressionAtlas; Q14318; baseline and differential.
DR   Genevisible; Q14318; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0005528; F:FK506 binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0043010; P:camera-type eye development; IEA:Ensembl.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IBA:GO_Central.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:CAFA.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR023566; PPIase_FKBP.
DR   InterPro; IPR001179; PPIase_FKBP_dom.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR013105; TPR_2.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR10516; PTHR10516; 1.
DR   Pfam; PF00254; FKBP_C; 1.
DR   Pfam; PF07719; TPR_2; 1.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50059; FKBP_PPIASE; 1.
DR   PROSITE; PS50005; TPR; 2.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Calcium;
KW   Complete proteome; Host-virus interaction; Isomerase; Isopeptide bond;
KW   Membrane; Metal-binding; Mitochondrion; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Rotamase; TPR repeat; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN         1    412       Peptidyl-prolyl cis-trans isomerase
FT                                FKBP8.
FT                                /FTId=PRO_0000075331.
FT   TRANSMEM    390    410       Helical. {ECO:0000255}.
FT   DOMAIN      120    204       PPIase FKBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   REPEAT      221    254       TPR 1.
FT   REPEAT      272    305       TPR 2.
FT   REPEAT      306    339       TPR 3.
FT   COMPBIAS     22     92       Glu-rich.
FT   METAL       149    149       Calcium.
FT   METAL       151    151       Calcium.
FT   MOD_RES     296    296       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    249    249       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    271    271       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    273    273       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    284    284       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    307    307       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    314    314       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    334    334       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    340    340       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    348    348       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    351    351       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   CROSSLNK    352    352       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:25621951}.
FT   VAR_SEQ      98    256       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:18385096}.
FT                                /FTId=VSP_047717.
FT   VAR_SEQ     183    183       G -> GS (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.8}.
FT                                /FTId=VSP_034486.
FT   VARIANT      87     87       A -> V (in dbSNP:rs11574806).
FT                                /FTId=VAR_044225.
FT   MUTAGEN     149    149       D->N: Abolishes calcium-binding and
FT                                reduces affinity for BCL2; when
FT                                associated with Asn-151.
FT                                {ECO:0000269|PubMed:20140889}.
FT   MUTAGEN     151    151       D->N: Abolishes calcium-binding and
FT                                reduces affinity for BCL2; when
FT                                associated with Asn-149.
FT                                {ECO:0000269|PubMed:20140889}.
FT   CONFLICT    144    144       V -> A (in Ref. 4; CAD98028).
FT                                {ECO:0000305}.
FT   CONFLICT    191    191       H -> R (in Ref. 4; CAD98028).
FT                                {ECO:0000305}.
FT   CONFLICT    206    206       G -> R (in Ref. 8; BAD96558).
FT                                {ECO:0000305}.
FT   STRAND       94    108       {ECO:0000244|PDB:3EY6}.
FT   STRAND      111    113       {ECO:0000244|PDB:2MF9}.
FT   STRAND      121    131       {ECO:0000244|PDB:3EY6}.
FT   STRAND      136    146       {ECO:0000244|PDB:3EY6}.
FT   TURN        147    150       {ECO:0000244|PDB:2MF9}.
FT   HELIX       154    157       {ECO:0000244|PDB:3EY6}.
FT   HELIX       160    162       {ECO:0000244|PDB:3EY6}.
FT   STRAND      168    173       {ECO:0000244|PDB:3EY6}.
FT   HELIX       175    177       {ECO:0000244|PDB:3EY6}.
FT   HELIX       180    182       {ECO:0000244|PDB:3EY6}.
FT   TURN        185    187       {ECO:0000244|PDB:3EY6}.
FT   STRAND      190    192       {ECO:0000244|PDB:2F2D}.
FT   STRAND      194    204       {ECO:0000244|PDB:3EY6}.
FT   STRAND      208    211       {ECO:0000244|PDB:2D9F}.
SQ   SEQUENCE   412 AA;  44562 MW;  887C25ADE71EBA8D CRC64;
     MASCAEPSEP SAPLPAGVPP LEDFEVLDGV EDAEGEEEEE EEEEEEDDLS ELPPLEDMGQ
     PPAEEAEQPG ALAREFLAAM EPEPAPAPAP EEWLDILGNG LLRKKTLVPG PPGSSRPVKG
     QVVTVHLQTS LENGTRVQEE PELVFTLGDC DVIQALDLSV PLMDVGETAM VTADSKYCYG
     PQGRSPYIPP HAALCLEVTL KTAVDGPDLE MLTGQERVAL ANRKRECGNA HYQRADFVLA
     ANSYDLAIKA ITSSAKVDMT FEEEAQLLQL KVKCLNNLAA SQLKLDHYRA ALRSCSLVLE
     HQPDNIKALF RKGKVLAQQG EYSEAIPILR AALKLEPSNK TIHAELSKLV KKHAAQRSTE
     TALYRKMLGN PSRLPAKCPG KGAWSIPWKW LFGATAVALG GVALSVVIAA RN
//
